Gut Microbiota and Type 2 Diabetes: Cinnamon the Promising Duo in Fighting against Diabetes- A Narrative Review

Saved in:
Bibliographic Details
Title: Gut Microbiota and Type 2 Diabetes: Cinnamon the Promising Duo in Fighting against Diabetes- A Narrative Review
Authors: Laiba Saher, Sahar Haseeb
Source: Liaquat National Journal of Primary Care, Vol 7, Iss 4, Pp 395-402 (2025)
Publisher Information: Liaquat National Hospital and Medical College, 2025.
Publication Year: 2025
Collection: LCC:Medicine (General)
Subject Terms: diabetes mellitus type 2, gastrointestinal microbiome, cinnamomum zeylanicum, hba1c levels, fasting glucose levels, metabolic health., Medicine (General), R5-920
Description: This narrative review aims to investigate how gut microbiota contributes to type 2 diabetes and how cinnamon may help regulate it. It draws attention to their combined effects on metabolic health and glycemic management. Cinnamon possesses properties that enhance insulin sensitivity and lower blood glucose levels for patients suffering from type 2 diabetes, and also plays a vital role in managing gut bacteria composition. The encouraging data limits researchers’ ability to make reliable judgments due to study design inconsistencies and missing standardized procedures. Although cinnamon shows promise in modulating gut microbiota and glycemic control, its therapeutic potential remains inconclusive. More comprehensive, well-designed clinical trials are essential to establish both the safety and efficacy of cinnamon supplementation in the context of Type 2 diabetes. Research into cinnamon’s impact on gut bacteria may improve its application as an additional treatment option. Future diabetic treatment plans may include cinnamon as a personalized therapeutic option. Through its anti-inflammatory and anti-oxidative characteristics, cinnamon maintains gut microbiota stability and aids in type 2 diabetes management. Cinnamon influences the production of short-chain fatty acids and regulates the brain axis, which leads to homeostasis management. A more comprehensive approach is required to understand cinnamon’s mechanism for the control of type 2 diabetes.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2707-3521
2708-9134
Relation: https://journals.lnh.edu.pk/lnjpc/pdf/bb4de1e8-2ea1-43d9-a437-e5661b7081e3.pdf; https://doaj.org/toc/2707-3521; https://doaj.org/toc/2708-9134
DOI: 10.37184/lnjpc.2707-3521.7.78
Access URL: https://doaj.org/article/f19d9be55c3545419008b8632c5b9e6f
Accession Number: edsdoj.f19d9be55c3545419008b8632c5b9e6f
Database: Directory of Open Access Journals
Description
Abstract:This narrative review aims to investigate how gut microbiota contributes to type 2 diabetes and how cinnamon may help regulate it. It draws attention to their combined effects on metabolic health and glycemic management. Cinnamon possesses properties that enhance insulin sensitivity and lower blood glucose levels for patients suffering from type 2 diabetes, and also plays a vital role in managing gut bacteria composition. The encouraging data limits researchers’ ability to make reliable judgments due to study design inconsistencies and missing standardized procedures. Although cinnamon shows promise in modulating gut microbiota and glycemic control, its therapeutic potential remains inconclusive. More comprehensive, well-designed clinical trials are essential to establish both the safety and efficacy of cinnamon supplementation in the context of Type 2 diabetes. Research into cinnamon’s impact on gut bacteria may improve its application as an additional treatment option. Future diabetic treatment plans may include cinnamon as a personalized therapeutic option. Through its anti-inflammatory and anti-oxidative characteristics, cinnamon maintains gut microbiota stability and aids in type 2 diabetes management. Cinnamon influences the production of short-chain fatty acids and regulates the brain axis, which leads to homeostasis management. A more comprehensive approach is required to understand cinnamon’s mechanism for the control of type 2 diabetes.
ISSN:27073521
27089134
DOI:10.37184/lnjpc.2707-3521.7.78